Free Trial

Oncimmune (ONC) Insider Trading & Ownership

Oncimmune logo
GBX 15.35 +0.20 (+1.32%)
(As of 11/22/2024 ET)

Oncimmune (LON:ONC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
30.97%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
£9,726.21
Number Of
Insiders Selling
(Last 12 Months)
0
Get ONC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Oncimmune stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ONC Insider Buying and Selling by Quarter

Oncimmune Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/8/2023Martin GouldstoneInsiderBuy36,023GBX 27£9,726.21
(Data available from 1/1/2013 forward)

ONC Insider Trading Activity - Frequently Asked Questions

The list of insiders at Oncimmune includes Adam Hill, and Martin Gouldstone. Learn more on insiders at ONC.

30.97% of Oncimmune stock is owned by insiders. Learn more on ONC's insider holdings.

The following insiders have purchased ONC shares in the last 24 months: Adam Hill (£10,157.70), and Martin Gouldstone (£9,726.21).

Insiders have purchased a total of 84,393 ONC shares in the last 24 months for a total of £19,883.91 bought.

Oncimmune Key Executives

  • Mr. Martin John Gouldstone (Age 58)
    CEO & Director
  • Mr. Martin Hudson
    Finance Director
  • Mr. Ron Kirschner (Age 45)
    COO, General Counsel & Company Secretary
  • Prof. Tariq Sethi B.Sc.
    FRCP, M.A., M.D., Ph.D., Chief Scientific Officer
  • Ms. Cléa Rosenfeld
    Head of Investor Relations
  • Mr. Maarten Brusse
    Chief Commercial Officer of Asia


This page (LON:ONC) was last updated on 11/24/2024 by MarketBeat.com Staff
From Our Partners